Market Overview:
The global mouse model market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for genetically engineered mice and rising prevalence of chronic diseases. In addition, technological advancements in the field of mouse modeling are also contributing to the growth of this market. Based on type, the global mouse model market is segmented into inbred mice, outbred mice, and genetically engineered mice. The inbred mouse segment is expected to account for the largest share of the global mouse model market during the forecast period. This segment is mainly driven by its low cost and easy availability as compared to other types of mouse models. Based on application, medical applications accounted for majority share of revenue generated by use of Mouse Model Market globally followed by pharmaceuticals sector with significant contribution coming from preclinical research studies which are used extensively across drug discovery process prior IND filing with regulatory agencies such as FDA (USA) or EMA (Europe).
Product Definition:
A mouse model is a living organism that has been genetically altered to more closely resemble a human disease. Mouse models are important for studying the biology of diseases and for developing new treatments.
Inbred Mice:
Inbred mice are genetically similar variants of the mouse breed that has been developed over many generations. The inbred mice have uniform genetic makeup and they share the same ancestors as humans do. This makes them a suitable experimental animal for researchers who want to study hereditary disorders in detail.
The most important factor contributing to the growth of this market is its usage by various research studies for drug discovery, toxicology testing, disease modeling & epidemiology etc.
Outbred Mice:
Outbred mice are genetically similar to each other and they can be used for testing the effects of a particular drug by administering it to one individual mouse and then observe the effect on another. This type of mice is widely used in research laboratories for testing various compounds, as they tend to have similar genetic makeup.
Outbred mice are genetically similar to each other and they can be used for testing the effects of a particular drug by administering it to one individual mouse.
Application Insights:
The other application segment includes research applications. The global market for other mouse models is expected to witness significant growth owing to the increasing use of these animals in toxicology and safety studies. In addition, the presence of prominent vendors such as Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., and Avantium NV provides a wide range of options for customizing products that are specifically designed for various applications.
The education segment held the largest share in 2017 due to extensive usage in educational settings across grade levels from K-12th. These animals have been used extensively as a teaching tool at an early age where children can observe human diseases first hand through animal models which has resulted in boosting this segment over the forecast period.
Regional Analysis:
North America dominated the global market in terms of revenue share in 2017. The region is expected to maintain its dominance over the forecast period due to factors such as increasing R&D activities, high healthcare spending, and growing adoption of technology. In addition, rising prevalence of chronic diseases and an increase in government funding for research are also contributing toward growth. Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to factors such as a rise in disposable income coupled with growing health awareness among people leading them toward better medical care which will drive demand for animal models used for testing drugs/biologicals products. Moreover, countries like Japan have a large number of genetically modified mice that are available for use worldwide thus making it one of the largest suppliers across this region (Kumar & Srivastava 2014).
Growth Factors:
- Increasing research and development expenditure by the pharmaceutical and biotechnology companies for novel drug discovery and development.
- Growing number of CROs providing mouse model services to support preclinical studies.
- Rising demand for genetically modified mice models for studying human diseases.
- Proliferation of personalized medicine approaches that require customized mouse models for each individual patient 5 Increased use of mouse models in toxicology studies to assess the safety of new drugs and chemicals
Scope Of The Report
Report Attributes
Report Details
Report Title
Mouse Model Market Research Report
By Type
Inbred Mice, Outbred Mice, Genetically Engineered Mice
By Application
Medical, Pharmaceutical, Education, Other
By Companies
Envigo, GenOway, Harbour Antibodies, Janvier Labs, Taconic Biosciences, The Jackson Laboratory, Charles River Laboratories International, Laboratory Corporation of America Holdings, Horizon Discovery Group, Trans Genic, Ingenious Targeting Laboratory
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
234
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Mouse Model Market Report Segments:
The global Mouse Model market is segmented on the basis of:
Types
Inbred Mice, Outbred Mice, Genetically Engineered Mice
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Medical, Pharmaceutical, Education, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Envigo
- GenOway
- Harbour Antibodies
- Janvier Labs
- Taconic Biosciences
- The Jackson Laboratory
- Charles River Laboratories International
- Laboratory Corporation of America Holdings
- Horizon Discovery Group
- Trans Genic
- Ingenious Targeting Laboratory
Highlights of The Mouse Model Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Inbred Mice
- Outbred Mice
- Genetically Engineered Mice
- By Application:
- Medical
- Pharmaceutical
- Education
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Mouse Model Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A mouse model is a type of animal model used in biomedical research. It is a small, typically furry, creature that can be studied in order to better understand human diseases or conditions.
Some of the major companies in the mouse model market are Envigo, GenOway, Harbour Antibodies, Janvier Labs, Taconic Biosciences, The Jackson Laboratory, Charles River Laboratories International, Laboratory Corporation of America Holdings, Horizon Discovery Group, Trans Genic, Ingenious Targeting Laboratory.
The mouse model market is expected to grow at a compound annual growth rate of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Mouse Model Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Mouse Model Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Mouse Model Market - Supply Chain
4.5. Global Mouse Model Market Forecast
4.5.1. Mouse Model Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Mouse Model Market Size (000 Units) and Y-o-Y Growth
4.5.3. Mouse Model Market Absolute $ Opportunity
5. Global Mouse Model Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Mouse Model Market Size and Volume Forecast by Type
5.3.1. Inbred Mice
5.3.2. Outbred Mice
5.3.3. Genetically Engineered Mice
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Mouse Model Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Mouse Model Market Size and Volume Forecast by Application
6.3.1. Medical
6.3.2. Pharmaceutical
6.3.3. Education
6.3.4. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Mouse Model Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Mouse Model Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Mouse Model Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Mouse Model Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Mouse Model Demand Share Forecast, 2019-2026
9. North America Mouse Model Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Mouse Model Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Mouse Model Market Size and Volume Forecast by Application
9.4.1. Medical
9.4.2. Pharmaceutical
9.4.3. Education
9.4.4. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Mouse Model Market Size and Volume Forecast by Type
9.7.1. Inbred Mice
9.7.2. Outbred Mice
9.7.3. Genetically Engineered Mice
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Mouse Model Demand Share Forecast, 2019-2026
10. Latin America Mouse Model Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Mouse Model Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Mouse Model Market Size and Volume Forecast by Application
10.4.1. Medical
10.4.2. Pharmaceutical
10.4.3. Education
10.4.4. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Mouse Model Market Size and Volume Forecast by Type
10.7.1. Inbred Mice
10.7.2. Outbred Mice
10.7.3. Genetically Engineered Mice
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Mouse Model Demand Share Forecast, 2019-2026
11. Europe Mouse Model Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Mouse Model Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Mouse Model Market Size and Volume Forecast by Application
11.4.1. Medical
11.4.2. Pharmaceutical
11.4.3. Education
11.4.4. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Mouse Model Market Size and Volume Forecast by Type
11.7.1. Inbred Mice
11.7.2. Outbred Mice
11.7.3. Genetically Engineered Mice
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Mouse Model Demand Share, 2019-2026
12. Asia Pacific Mouse Model Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Mouse Model Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Mouse Model Market Size and Volume Forecast by Application
12.4.1. Medical
12.4.2. Pharmaceutical
12.4.3. Education
12.4.4. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Mouse Model Market Size and Volume Forecast by Type
12.7.1. Inbred Mice
12.7.2. Outbred Mice
12.7.3. Genetically Engineered Mice
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Mouse Model Demand Share, 2019-2026
13. Middle East & Africa Mouse Model Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Mouse Model Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Mouse Model Market Size and Volume Forecast by Application
13.4.1. Medical
13.4.2. Pharmaceutical
13.4.3. Education
13.4.4. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Mouse Model Market Size and Volume Forecast by Type
13.7.1. Inbred Mice
13.7.2. Outbred Mice
13.7.3. Genetically Engineered Mice
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Mouse Model Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Mouse Model Market: Market Share Analysis
14.2. Mouse Model Distributors and Customers
14.3. Mouse Model Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Envigo
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. GenOway
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Harbour Antibodies
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Janvier Labs
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Taconic Biosciences
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. The Jackson Laboratory
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Charles River Laboratories International
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Laboratory Corporation of America Holdings
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Horizon Discovery Group
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Trans Genic
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Ingenious Targeting Laboratory
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
